Evidence map›Paper›PMID 24196348›Full record

ArticleJAMA psychiatry2014

In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

Fei Du, Alissa J Cooper, Thida Thida, Selma Sehovic, Scott E Lukas, Bruce M Cohen, Xiaoliang Zhang, Dost Ongür

Open access · greenAbstract read
In one paragraph

Article in JAMA psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 4 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 4 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Pooled it
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Creatine kinase imaging (CKI) for in vivo whole-brain mapping of creatine kinase reaction kinetics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Fast 3DMagnetic resonance in medicine · 2025
    Article
  18. Atlas of plasma metabolic markers linked to human brain morphology.bioRxiv : the preprint server for biology · 2025
    Article
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fei DuPsychotic Disorders Division, McLean Hospital, Belmont, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Alissa J CooperPsychotic Disorders Division, McLean Hospital, Belmont, Massachusetts.
Thida ThidaPsychotic Disorders Division, McLean Hospital, Belmont, Massachusetts.
Selma SehovicPsychotic Disorders Division, McLean Hospital, Belmont, Massachusetts.
Scott E LukasDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts3McLean Imaging Center, McLean Hospital, Belmont, Massachusetts.
Bruce M CohenDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts4Shervert Frazier Research Institute, McLean Hospital, Belmont, Massachusetts.
Xiaoliang ZhangDepartment of Radiology, University of California, San Francisco.
Dost OngürPsychotic Disorders Division, McLean Hospital, Belmont, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Harvard University · USMcLean Hospital · USUniversity of California, San Francisco · US

Funding

Training In Drug Abuse and Brain ImagingT32DA015036 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI SCOTT E LUKAS · 2002 to 2026
$5.3M
Probing the White Matter in Schizophrenia Using Novel MRS TechniquesR01MH094594 · NIMH · MCLEAN HOSPITAL · PI ONGUR, DOST · 2011 to 2015
$1.8M
Novel 31P MRS Approach for Measuring Abnormal Bioenergetics in SchizophreniaR21MH092704 · NIMH · MCLEAN HOSPITAL · PI DU, FEI · 2011 to 2012
$410k
NIDA NIH HHS T32 DA015036NIDA NIH HHS T32DA015036NIMH NIH HHS R01 MH094594NIMH NIH HHS R01MH094594NIMH NIH HHS R21 MH092704NIMH NIH HHS R21MH092704
6 · The paper itself

Abstract

importanceAbnormalities in neural activity and cerebral bioenergetics have been observed in schizophrenia (SZ). Further defining energy metabolism anomalies would provide crucial information about molecular mechanisms underlying SZ and may be valuable for developing novel treatment strategies.

objectiveTo investigate cerebral bioenergetics in SZ via measurement of creatine kinase activity using in vivo 31P magnetization transfer spectroscopy. DESIGN, SETTING, AND

participantsCross-sectional case-control study in the setting of clinical services and a brain imaging center of an academic psychiatric hospital. Twenty-six participants with chronic SZ (including a subgroup diagnosed as having schizoaffective disorder) and 26 age-matched and sex-matched healthy control subjects (25 usable magnetic resonance spectroscopy data sets from the latter).

intervention31P magnetization transfer spectroscopy. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the forward rate constant (k(f)) of the creatine kinase enzyme in the frontal lobe. We also collected independent measures of brain intracellular pH and steady-state metabolite ratios of high-energy phosphate-containing compounds (phosphocreatine and adenosine triphosphate [ATP]), inorganic phosphate, and the 2 membrane phospholipids phosphodiester and phosphomonoester.

resultsA substantial (22%) and statistically significant (P = .003) reduction in creatine kinase kf was observed in SZ. In addition, intracellular pH was significantly reduced (7.00 in the SZ group vs 7.03 in the control group, P = .007) in this condition. The phosphocreatine to ATP ratio, inorganic phosphate to ATP ratio, and phosphomonoester to ATP ratio were not substantially altered in SZ, but a significant (P = .02) reduction was found in the phosphodiester to ATP ratio. The abnormalities were similar between SZ and schizoaffective disorder. CONCLUSIONS AND RELEVANCE: Using a novel 31P magnetization transfer magnetic resonance spectroscopy approach, we provide direct and compelling evidence for a specific bioenergetic abnormality in SZ. Reduced kf of the creatine kinase enzyme is consistent with an abnormality in storage and use of brain energy. The intracellular pH reduction suggests a relative increase in the contribution of glycolysis to ATP synthesis, providing convergent evidence for bioenergetic abnormalities in SZ. The similar phosphocreatine to ATP ratios in SZ and healthy controls suggest that the underlying bioenergetics abnormality is not associated with change in this metabolite ratio.

Indexed as

Magnetic Resonance SpectroscopyAdenosine TriphosphateAdultBrainBrain ChemistryCase-Control StudiesCreatine KinaseCross-Sectional StudiesEnergy MetabolismFemaleFrontal LobeHumansHydrogen-Ion ConcentrationMalePhosphocreatinePhosphorus IsotopesAdenosine TriphosphateCreatine KinasePhosphocreatinePhosphorus Isotopes

Identifiers

PMID24196348
PMCPMC7461723
OpenAlexW2061510013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.